Similarly, in a cohort of 16 healthy human volunteers, LY3526318 administration (10, 30, and 100mg, p.o.) dose-dependently reduced the elevated blood flow surrounding the site of 10% v/v cinnamaldehyde application, with a trend toward inhibition at the site of application. Comparisons between...